Enjoy complimentary customisation on priority with our Enterprise License!
The insulin market size is estimated to grow by USD 1.29 billion at a CAGR of 1.38% between 2023 and 2028. The market is witnessing substantial growth due to the escalating number of diabetes cases and technological advancements in insulin delivery systems. According to the International Diabetes Foundation, an estimated 463 million adults were diagnosed with diabetes in 2019, and this figure is predicted to reach 700 million by 2045. The burgeoning diabetes burden, including type 2 diabetes, is fueling a robust demand for insulin and associated products. Moreover, advancements in insulin delivery systems, such as insulin pumps, continuous glucose monitoring systems, insulin syringes, and pen injectors, are improving the convenience and efficacy of insulin therapy. However, this market encounters challenges, including stringent regulatory approvals for new products and intensifying competition from generic insulin manufacturers.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.